期刊文献+

重组人内抑素对佐剂性关节炎大鼠滑膜细胞增殖及产生细胞因子的影响 被引量:17

Effect of recombinant human endostatin on proliferation and cytokines production of synoviocytes from adjuvant arthritis rats in vivo
下载PDF
导出
摘要 目的观察重组人内抑素对体外培养佐剂性关节炎大鼠滑膜细胞的增殖功能及产生细胞因子的影响,探讨其治疗佐剂性关节炎的作用机制。方法采用弗氏完全佐剂(CFA)诱导的佐剂性关节炎(AA)大鼠模型,用足容积法测量关节肿胀度;采用collagenasetypeⅡ消化法分离、培养滑膜细胞,MTT法检测重组人内抑素体内用药对滑膜细胞增殖的影响;放免法检测滑膜细胞上清液中IL-1β、TNF-α的含量。结果CFA致炎后d10,AA大鼠出现继发性炎症,此时皮下注射重组人内抑素(1·25,2·5,5mg·kg-1),连续7d,对照组于d10给予MTX(1·0mg·kg-1)。各剂量组能明显抑制AA大鼠的继发性足肿胀;重组人内抑素体内用药可明显减少AA大鼠滑膜细胞数量,抑制滑膜细胞的增殖,并呈剂量依赖关系;各剂量组均可明显抑制AA大鼠滑膜细胞产生过高的IL-1β和TNF-α。结论重组人内抑素抑制AA大鼠滑膜细胞过度的增殖及过高的细胞因子是其治疗AA的途径之一。 Aim To study the effect of recombinant human endostatin on proliferation and secretion of cytokines on synoviocyte from adjuvant arthritis (AA) rats in vivo, and to investigate the therapeutical mechanism of recombinant human endostatin on AA rats. Methods Adjuvant arthritis rat model was induced by a single intradermal injection of 100μl of CFA on d 0. The volume of rat hind paw was measured by means of Volume Meter. Synoviocytes from rat knees were excised and dispersed with sequential incubation of the collagenase type Ⅱ and trypsin. The proliferation of synoviocytes was measured by MTT; activities of IL-1β and TNF-α produced by synoviocytes were estimated with radioimmunoassay. Results The secondary inflammation of AA rats appeared on the d10 after injection of CFA.The therapeutic administration of recombinant human ( 1.25,2.5,5.0 mg · kg^- 1 ) were given from that time (d10). Methotrexate(MTX, 1.0 mg · kg^-1) was given only once on d10. Recombinant human endostatin significantly reduced the secondary paw swelling and decreased the production of IL-1β and TNF-α from synovial supernatants. Recombinant human endostatin resulted in a dose-dependent reduction in the number of synoviocytes and inhibited the proliferation of synovial in vivo. Conclusion Recombinant human endostatin had an inhibitory effect on AA rats, which was related to its inhibition of proliferation and secretion of synoviocytes.
出处 《中国药理学通报》 CAS CSCD 北大核心 2007年第1期59-63,共5页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30572196)
关键词 重组人内抑素 佐剂性关节炎 滑膜细胞 增殖 细胞因子 recombinant human endostatin adjuvant arthritis synoviocytes proliferation cytokines
  • 相关文献

参考文献20

  • 1Zvaifler N J,Boyle D,Firestein G S.Early synovitis-synoviocytes and mononuclear cells[J].Semin Arthritis Rheum,1994,23:11.
  • 2Feldmann M,Brennan F M,Maini R N.Role of cytokines in rheumatoid arthritis[J].Annu Rev Immunol,1996,14:397.
  • 3Firestein G S.Evolving concepts of rheumatoid arthritis[J].Nature,2003,23:356-61.
  • 4陈飞虎.肿瘤血管生成抑制因子及Endostatin研究进展[J].安徽医药,2003,7(1):5-7. 被引量:9
  • 5Fenton B M,Paoni S F,Beauchamp B K,et al.Evaluation of microregional variations in tumor hypoxia following the administration of endostatin[J].Adv Exp Med Biol,2003,510:19-24.
  • 6Ponnazhagan S,Mahendra G,Kumar S,et al.Adeno-associated visus 2-mediated antiangiogenic cancer gene therapy:long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor[J].Cancer Res,2004,64(5):1781-7.
  • 7Nap A W,Griffioen A W,Dunselman G A,et al.Antiangiogenesis Therapy for Endostatin[J].J Clin End Metab,2004,89(3):1089-95.
  • 8岳莉,沈玉先,王华,刘丽华,郑咏秋,魏伟,徐叔云.重组人内抑素对大鼠佐剂性关节炎继发性炎症的抑制作用[J].中国药理学通报,2003,19(8):899-903. 被引量:16
  • 9刘雯,李守新.类风湿关节炎成纤维样滑膜细胞凋亡研究进展[J].中华风湿病学杂志,2005,9(10):620-622. 被引量:8
  • 10Tallia A F,Cardone D A.Diagnostic and therapeutic injection of the shoulder region[J].Am Fam Physician,2003,67(6):1271-8.

二级参考文献60

  • 1丰俊东,徐晓玉,胡益勇,陈刚,陈伟海,杨丽蓉.川芎嗪对VEGF受体与其放射性配体结合的抑制[J].中国药理学通报,2005,21(8):939-942. 被引量:14
  • 2[1]OReilly MS, Holmgren L, Shing Y et al. Angiostatin:A novel angiogenesis inhibitor that mediates the suppression of metasta ses by a Lewis lung carcinoma, Cell, 1994;79(2) :315~28
  • 3[2]OReilly MS, Boehm T, Shing Y et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth, Cell, 1997;88 (2):277~85
  • 4[3]Standker L, Schrader M, Kanse SM et al. Isolation and charac terization of the circulating from of human endostatin, FEBSLett, 1997;420(2~3) :129~33
  • 5[4]Ferreras M, Felbor U, Lenhard T et al. Generation and degradation of human endostatin proteins by variors proteinases. FEBS Lett, 2000 ;486(3) :247~51
  • 6[5]Iughetti P, Suzuki O, Godoi PHC et al. A polymorphism in en dostatin, an angigenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Res, 2001; 61 (20): 7375~8
  • 7[6]Miosge N, Sasaki T, Timpl R. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. Faseb J, 1999;13(13) :1743~50
  • 8[7]Annual meeting, American society of clinical oncology (ASCO), May, 2001. San Francisco of California
  • 9[8]Kasai S, Nagasawa H, Shimamura M et al. Design and synthesis of antiangiogenic/heparin-binding arginine dendrimer mimicking the surface of endostatin. Bioorganic & Medicinal Chemistry Letters, 2002 ; 12:951 ~ 4
  • 10[9]Hohenester E,Sasaki T ,Mann K et al. Variable zinc coordination in endostatin. J Mol Biol, 2000; 297 (1): 1 ~ 6

共引文献48

同被引文献174

引证文献17

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部